Preliminary simulations [BE/BA News]

posted by ElMaestro  – Denmark, 2022-04-30 21:10 (400 d 04:26 ago) – Posting: # 22946
Views: 2,161

Hi Hötzi,

your post is potentially highly significant.

❝ Is this really the intention? The wider the range in tmax, the more easily products will pass. Counterintuitive.


The intention, as I understand it, was exactly the opposite. It goes completely against all intention, doesn't it?
I think this knowledge, if it holds in confirmatory simulations, should be published quickly and made available to regulators.

I very much hope that regulators will abstain completely from letting pride prevail over the regard for the EU patient. So I hope they will not dismiss the argumentation. For example, I could fear they would dismiss your findings because they don't have a palate for simulations (but note they like simulations well enough when it comes to f2; bootstrapping is a simulation, too).

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,616 posts in 4,740 threads, 1,613 registered users;
26 visitors (0 registered, 26 guests [including 15 identified bots]).
Forum time: 01:37 CEST (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5